Taiwan company seeks local partners to drive healthcare innovation

Taiwan company seeks local partners to drive healthcare innovation

Doctors examine a COVID-19 patient in the emergency room of the Wisma Atlet Emergency Hospital, Jakarta on March 28, 2020. (ANTARAS / HO-Kogasgabdap Health Team, Wisma Atlet)

Jakarta (ANTARA) - Taiwanese technology company Imedtac is seeking local partners in Indonesia to help develop integrated medical devices using technology to improve the national health system and reduce the rate of COVID-19 transmission.

“We are looking for local partners in Indonesia so that the vision to change medical care to be more sophisticated, easier, and more practical will soon be realized,” Imedtac’s business development manager, Bereh Hsieh, said in an official statement in Jakarta on Wednesday.

The Taipei-based company plans to combine artificial intelligence (AIoT) technology and the Internet of Medical Things (IoMT) to connect all health devices to the internet through its platform, so that patient data can be accessed in real time.

This integration will make it easier for health workers to analyze and transmit medical data quickly, Bereh stressed.

Therefore, he continued, the innovation would increase efficiency, lower cost of care, and drive better outcomes in healthcare.

For patients and physicians, the app would play a key role in tracking and preventing chronic disease, he noted.

“Our company wants to combine both of them. We want to quantify our technology and knowledge in IoM and IoMT devices and combine this with our experience and training as well as our good reputation in medical and hospital services," Bereh said.

Under the old paradigm for health services, patients had to queue up to see a doctor, without knowing how long it would take and they also did not know what needed to be done, he added.

The new technology would help overcome these obstacles, he pointed out.

"Many countries in Southeast Asia, even Taiwan, have (had) problems with our hospital (RS). The hospitals have too many people and too many patients. The patients waited to see an unknown doctor for how long. In Vietnam, it usually takes them two hours or even more to see a doctor,” he explained.

This, Bereh noted, is a big problem, especially in the new normal era amid the COVID-19 pandemic.

Imedtac’s technology would help prevent such crowding as all information related to patients would be processed into digital data, or big data, he explained.

So, hospital managers would know how to improve their workflow, and health workers would be able to monitor all information related to patients very quickly, even remotely, he noted.

One of the goals of using this technology is to allow the switch from doctor-centered to patient-centered care, which will increase the efficiency of time spent in the health consultation process, Bereh said.

Recently, hospitals have been called on to digitize, he pointed out.

Drug safety

Bereh said Imedtac is also providing solutions related to drug safety through its technology as only authorized parties can access drugs using its platform.

“So, we can prevent medication errors in this case. Of course, all information will be connected to the hospital information system and pharmacist information system. We will make sure all the recipes are correct and the recipe can only open the right drawer for the right medicine,” he explained.

The company’s AI-based tool has been marketed in all Taiwan hospitals and several hospitals in Thailand and Vietnam, he said.

Imedtac is also targeting the Saudi Arabian and Indonesian markets, he added.

It is targeting sales of 100 thousand US dollars in the first year and one million US dollars in the second year in Indonesia for its product.

Imedtac chalked up sales of US$4 million in 2019, and they are projected to increase to US$6 million in 2020 and US$12 million in 2021.  

Related news: Ishihara Charity Foundation donates 140 thousand PPEs to Indonesia
Related news: A closer look at Taiwan's efforts to tackle COVID-19